Crosstalk between PD-1/PD-L1 blockade and its combinatorial therapies in tumor immune microenvironment: a focus on HNSCC

W Lin, M Chen, L Hong, H Zhao, Q Chen - Frontiers in oncology, 2018 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy
worldwide with a poor prognosis and high mortality. More than two-thirds of HNSCC patients …

The prognostic and therapeutic value of the mutational profile of blood and tumor tissue in head and neck squamous cell carcinoma

HL Wilson, RB D'Agostino Jr, N Meegalla… - The …, 2021 - academic.oup.com
Background The purpose of this study was to explore the genomic landscape of head and
neck squamous cell carcinoma (HNSCC) in circulation (circulating tumor DNA [ctDNA]) and …

[HTML][HTML] Window of opportunity trials in head and neck cancer

JL Farlow, AC Birkeland, PL Swiecicki… - Journal of cancer …, 2019 - ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC) has a large global burden of disease
and poor survival outcomes. Recent targeted therapies and immunotherapies have been …

[HTML][HTML] Germline variants in DNA repair genes are associated with young-onset head and neck cancer

SS Cury, PM de Miranda, FA Marchi, LM do Canto… - Oral oncology, 2021 - Elsevier
The genetic predisposition to head and neck carcinomas (HNSCC) and how the known risk
factors (papillomavirus infection, alcohol, and tobacco consumption) contribute to the early …

Prevalence of DNA repair gene mutations in blood and tumor tissue and impact on prognosis and treatment in HNSCC

KM Burcher, AT Faucheux, JW Lantz, HL Wilson… - Cancers, 2021 - mdpi.com
Simple Summary The DNA damage repair (DDR) gene profile is largely unexplored in head
and neck squamous cell cancer (HNSCC), leaving little known about the treatment of …

Clinical implication of genetic intratumor heterogeneity for targeted therapy in head and neck cancer

SB Gram, D Alosi, FO Bagger, O Østrup… - Acta …, 2023 - Taylor & Francis
Background Genomic profiling is increasingly used both in therapeutic decision-making and
as inclusion criteria for trials testing targeted therapies. However, the mutational landscape …

The Wnt-driven Mll1 epigenome regulates salivary gland and head and neck cancer

Q Zhu, L Fang, J Heuberger, A Kranz, J Schipper… - Cell Reports, 2019 - cell.com
We identified a regulatory system that acts downstream of Wnt/β-catenin signaling in salivary
gland and head and neck carcinomas. We show in a mouse tumor model of K14-Cre …

[HTML][HTML] Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition

E Klapproth, E Dickreuter, F Zakrzewski, M Seifert… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Intrinsic and acquired resistances are major obstacles in cancer therapy. Genetic
characterization is commonly used to identify predictive or prognostic biomarker signatures …

Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines

K Schneider, V Bol, V Grégoire - Radiotherapy and Oncology, 2017 - Elsevier
Background and purpose Clinical studies indicate that patients with HPV/p16-associated
head & neck squamous cell carcinoma (HNSCC) represent a subgroup with a better …

Whole-exome sequencing of sinonasal small cell carcinoma arising within a papillary schneiderian carcinoma in situ

J Smith, A Kulkarni, AC Birkeland… - … –Head and Neck …, 2018 - journals.sagepub.com
Objective The pathogenetic underpinnings of extrapulmonary small cell carcinomas
(EPSCCs) of the head and neck are poorly understood. We sought to describe the clinical …